The U.S. Food and Drug Administration has approved Juvisync (sitagliptin and simvastatin), the first combination drug to treat type 2 diabetes and high cholesterol in one tablet. Read…
Reader Survey
Please share your feedback! We’re interested to learn more about your experience with American Nurse Journal.